Skip to main content
Clinical Trials/NCT02530840
NCT02530840
Unknown
Not Applicable

Impact:Improving Adherence and Commitment to Treatment

Clalit Health Services1 site in 1 country500 target enrollmentJuly 2014
ConditionsType 2 Diabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type 2 Diabetes
Sponsor
Clalit Health Services
Enrollment
500
Locations
1
Primary Endpoint
Diabetes Control as Expressed by the Change in HbA1c %
Last Updated
8 years ago

Overview

Brief Summary

In the IMPACT project, the investigators want to improve adherence and commitment to treatment.

Detailed Description

In this study the investigators use 3 interventions in diabetic patients and one control, to find what is the best intervention to improve adherence to healthy life style and medication therapy. the 3 intervention as followed: 1) meetings and follow-up by the medical team; 2) meetings and follow-up by trained peers; 3) system for sending SMS, operate according to algorithm.

Registry
clinicaltrials.gov
Start Date
July 2014
End Date
March 2018
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • type 2 diabetes
  • Oral medication or insulin
  • According to the HbA1c test result, 0.5% above the target for the patient's personal balance and below the 10%, the most recent, but in any event not more than six months prior to the study patient recruitment
  • Patients speak and read Hebrew
  • owners of a mobile phone that can receive text messages (SMS messages/ notifications) and have the ability to use the application (relevant for the SMS notification arm)

Exclusion Criteria

  • Active malignant disease
  • creatinine levels above 2
  • Getting medicines that elevate sugar levels as steroids, chemotherapy
  • Three months after Myocardial Infraction (myocardial ischemia), surgical intervention, cardiac event
  • Patients who are planning major surgery
  • Patients who are planning a residential zone change
  • Patients with acute complications of diabetes under active treatment (such as limb amputation)
  • Patients diagnosed with unbalanced mental disorders
  • patients who can not sign the form on their own "informed consent"
  • patients suffering from dementia

Outcomes

Primary Outcomes

Diabetes Control as Expressed by the Change in HbA1c %

Time Frame: 0, 6, 12 & 18 months

Participants will undergo HbA1c periodical lab test, the data needed for the trial will be extracted from electronic medical record

Study Sites (1)

Loading locations...

Similar Trials